Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of SLC-391 in Healthy Adult Subjects
Clinical trial NCT05278845 · COMPLETED
Trial details
- NCT number
- NCT05278845
- Sponsor
- SignalChem Lifesciences Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-12
- Primary completion
- 2022-06-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.